Catalyst Pharmaceutical Partners Inc buy melinda
Start price
31.10.18
/
50%
€2.72
Target price
01.11.18
€2.89
Performance (%)
6.98%
End price
01.11.18
€2.90
Summary
This prediction ended on 01.11.18 with a price of €2.90. With a performance of 6.98%, the BUY prediction by melinda for Catalyst Pharmaceutical Partners Inc closed with a slight gain. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Catalyst Pharmaceutical Partners Inc | -2.918% | -2.918% | 33.904% | 210.556% |
| iShares Core DAX® | -0.258% | -0.962% | 15.475% | 16.944% |
| iShares Nasdaq 100 | 2.964% | 4.747% | 30.457% | 56.973% |
| iShares Nikkei 225® | 1.217% | 0.285% | 5.780% | 5.634% |
| iShares S&P 500 | 1.732% | 2.635% | 25.189% | 48.524% |
Comments by melinda for this prediction
In the thread Catalyst Pharmaceutical Partners Inc diskutieren
Soins de santé | Drogues - Générique | Etats-Unis
Develops and commercializes prescription drugs
Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company.
It focuses on development and commercialization of prescription drugs targeting rare (orphan) neuromuscular and neurological diseases, including Lambert-Eaton Myasthenic Syndrome (LEMS), infantile spasms, and Tourette's disorder.
The company was founded by McEnany J. Patrick and Huckel E. Hubert in January 2002 and is headquartered in Coral Gables, FL.
Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company.
It focuses on development and commercialization of prescription drugs targeting rare (orphan) neuromuscular and neurological diseases, including Lambert-Eaton Myasthenic Syndrome (LEMS), infantile spasms, and Tourette's disorder.
The company was founded by McEnany J. Patrick and Huckel E. Hubert in January 2002 and is headquartered in Coral Gables, FL.
Nombre d'employés : 21 personnes.
Stopped prediction by melinda for Catalyst Pharmaceutical Partners Inc
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€2.84
05.01.21
05.01.21
€3.50
05.01.22
05.01.22
100.71%
06.01.22
06.01.22
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€3.11
11.05.19
11.05.19
€3.61
03.07.19
03.07.19
17.05%
03.07.19
03.07.19
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€1.29
22.10.13
22.10.13
€1.50
22.04.14
22.04.14
12.39%
22.04.14
22.04.14
Catalyst Pharmaceutical Partners Inc
Start price
Target price
Perf. (%)
€2.44
08.10.13
08.10.13
€2.00
22.10.13
22.10.13
-45.91%
22.10.13
22.10.13